BIOLASE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 7 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-08-29: Reporting owner LORD JONATHAN T MD; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-08-27: Reporting owner MOLL FREDERIC H; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-08-27: Reporting owner TALEVICH JAMES R; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-08-27: Reporting owner CLARK PAUL N; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-08-29 | LORD JONATHAN T MD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,745 69,173 owned after | $2.16 exercise price | 2014-09-03 | |
| 2014-08-27 | MOLL FREDERIC H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,428 98,678 owned after | $2.17 exercise price | 2014-08-29 | |
| 2014-08-27 | TALEVICH JAMES R Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,428 68,928 owned after | $2.17 exercise price | 2014-08-29 | |
| 2014-08-27 | CLARK PAUL N Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,428 65,178 owned after | $2.17 exercise price | 2014-08-29 | |
| 2014-08-27 | LORD JONATHAN T MD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,428 41,428 owned after | $2.17 exercise price | 2014-08-29 | |
| 2014-07-23 holding as of filing | CLARK PAUL N Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.03 exercise price | 2014-07-23 | ||
| 2014-07-13 | Nugent Jeffrey M Director, Officer (Acting Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +172,282 172,282 owned after | $1.98 exercise price | 2014-07-23 |